Anthera Pharma (ANTH) Posts Q2 Loss of $0.36, Wider than Views
Tweet Send to a Friend
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) reports Q2 loss of $0.36, versus the analyst estimate of ($0.25).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Raven Industries, Inc. (RAVN) Misses Q1 EPS by 6c
- CNinsure, Inc. (CISG) Q1 EPS Falls to RMB0.67
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
